Cheng Ni | Health Sciences | Best Researcher Award | 13442

Prof. Cheng Ni | Health Sciences | Best Researcher Award

Prof. Cheng Ni, Cancer Hospital, Chinese Academy of Medical Sciences, China

Prof. Cheng Ni, M.D., Ph.D. is a Professor and Consultant Anesthesiologist at the Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, where he also serves as Associate Chief of the Department of Anesthesiology. With extensive clinical and academic experience in thoracic anesthesiology, perioperative neuroprotection, and cancer pain management, Prof. Ni has held key roles at leading institutions including Peking University and Harvard University. His research focuses on perioperative neurocognitive disorders, tumor immunology, and the application of AI in anesthesiology. He has published over 50 SCI-indexed articles and holds 11 authorized patents.

Profile

Scopus

🎓 Early Academic Pursuits

Prof. Cheng Ni’s academic journey is a testament to dedication and intellectual rigor. He began his medical education at Capital Medical University, earning his M.D. in 2003 and M.S. in 2005, laying a solid foundation in medical sciences. His passion for deeper understanding and specialization led him to pursue a Ph.D. at Peking University, one of China’s most prestigious institutions, which he completed in 2012. This advanced academic training equipped him with a rich knowledge base in anesthesiology and related biomedical sciences, paving the way for a distinguished career in clinical practice, teaching, and research.

🩺 Professional Endeavors

Prof. Ni’s professional career reflects a steady and impactful rise through China’s top-tier medical institutions. He began as a Resident at Peking University Third Hospital (2005–2008) and subsequently served as an Attending Anesthesiologist (2008–2015). During this period, he gained hands-on clinical experience and honed his leadership abilities.

In 2013–2014, he expanded his global perspective as a Postdoctoral Research Fellow at Harvard University, engaging with cutting-edge international research. Upon his return, he held several key administrative and academic roles at Peking University, including Chief Secretary of the Faculty of Anesthesiology, and Associate Consultant and Associate Professor.

In 2020, Prof. Ni joined the Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, a top national institution, as a Consultant and Associate Professor. His expertise quickly earned him leadership roles as Associate Chief of the Department of Anesthesiology, and by 2021, he was promoted to Professor and Consultant. He also became a Ph.D. Supervisor in 2023, mentoring the next generation of clinical researchers and specialists.

🔬 Contributions and Research Focus

Prof. Ni’s research contributions span multiple high-impact areas in modern anesthesiology and cancer care. His primary interests include:

  • Perioperative neurocognitive disorders 🧠

  • Thoracic anesthesiology and neuroprotection 💨🛡️

  • Cancer pain management 🧬

  • Genetics and tumor immunology 🧫

  • AI in anesthesiology research 🤖🩺

He has authored over 50 peer-reviewed articles in leading SCI-indexed journals, including Aging Cell, CNS Neuroscience & Therapeutics, Life Sciences, and Anesthesia & Analgesia. His recent publications explore the neuroinflammatory response during surgery, the effects of anesthesia on brain aging, and the integration of hybrid learning models for brain cell identification—blending medical science with artificial intelligence.

In addition to journal publications, Prof. Ni has contributed to 12 academic monographs and holds 11 authorized patents, underscoring his commitment to translational research and innovation.

🏅 Accolades and Recognition

Prof. Cheng Ni is widely respected in China’s medical and academic communities. His achievements have been recognized through his appointment to senior roles such as:

  • Chief Secretary of Anesthesiology Faculty, Peking University Health Science Center

  • Associate Chief of the Department of Anesthesiology at China’s National Cancer Center

  • Ph.D. Supervisor, guiding graduate-level research and fostering academic excellence

These appointments are not only acknowledgments of his skill and dedication but also affirmations of his influence in shaping anesthesiology and cancer care practices in China.

🌍 Impact and Influence

Prof. Ni’s work resonates far beyond the operating room. His integration of AI into anesthesiology research marks a forward-thinking approach to modern medicine. By exploring the cognitive effects of anesthesia, he contributes to improving surgical outcomes and patient safety, particularly in aging populations.

His leadership and mentorship roles at premier institutions like Peking University and the Cancer Hospital, CAMS, have helped nurture a generation of professionals equipped with both technical excellence and ethical insight.

Furthermore, his international collaboration with Harvard University has brought valuable cross-cultural research experience into Chinese clinical research settings, promoting a global standard in anesthesiology and perioperative medicine.

🌱 Legacy and Future Contributions

Looking ahead, Prof. Ni is poised to play a pivotal role in shaping the future of anesthesiology in cancer care. His continued emphasis on neuroprotection, chronic pain management, and artificial intelligence applications signals a progressive vision aligned with global health priorities.

As a Ph.D. supervisor and seasoned educator, his mentorship will continue to inspire emerging scholars. His innovations in clinical protocols and diagnostic tools will likely set new benchmarks in anesthetic safety and cancer patient recovery.

Prof. Cheng Ni stands as a bridge between tradition and innovation, combining deep clinical knowledge with research excellence to lead transformative change in anesthesiology and oncology care.

Publication Top Notes

Author: Z., Suo, Zizheng, T., Xiao, Ting, Y., Qu, Yinyin, H., Zheng, Hui, C., Ni, Cheng

Year: 2024

 

Valery Likhvantsev | Medicine and Health Sciences | Russia

Prof Dr. Valery Likhvantsev | Medicine and Health Sciences | Russia

Deputy Director at Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology, Russia.

Amjad Alipanah is an esteemed Associate Professor of Applied Mathematics at the University of Kurdistan, Sanandaj, Iran. Born on September 23, 1974, he has a distinguished academic background with a BSc in Mathematics from the University of Kurdistan and both an MSc and PhD in Applied Mathematics from AmirKabir University, Tehran, Iran. His research focuses on spectral and pseudospectral methods, finite difference methods, calculus of variations, approximation theory, and numerical analysis. With a robust portfolio of journal publications and conference papers, he has significantly contributed to the field. Alipanah is also a dedicated educator, teaching a variety of undergraduate and graduate courses and supervising numerous postgraduate theses. His work has earned him top ranks as a graduate student and a prominent position in the academic community. 🌐✨

Professional Profiles:

Education

Valery Likhvantsev’s education details are not explicitly provided in the information available. To accurately provide his educational background, additional specific details about his academic journey, such as the institutions he attended, degrees he obtained, and fields of study, would be required. However, considering his high level of research activity and professional accomplishments, it can be inferred that he has a robust educational foundation in medicine or a related field, likely including advanced degrees such as an MD or PhD.

Professional Experience

Valery Likhvantsev is currently affiliated with the Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology since 2020. His extensive professional experience spans various roles and contributions to the field of anesthesiology and intensive care. Likhvantsev has authored and co-authored numerous publications in high-impact journals, reflecting his active engagement in clinical research and his commitment to advancing medical knowledge in his specialty. His work includes significant contributions to contemporary clinical trials, systematic reviews, and meta-analyses, focusing on topics such as neurocognitive disorders, sepsis, and postoperative outcomes. His professional journey underscores a deep commitment to clinical excellence and research innovation in critical care medicine.

Research Interest

Valery Likhvantsev’s research interests primarily revolve around anesthesiology and intensive care medicine. His work extensively covers the effects of anesthetics on postoperative neurocognitive disorders, the use of anti-inflammatory agents in sepsis, and strategies to reduce postoperative agitation through innovative anesthetic techniques. Likhvantsev is also keenly interested in the application of trial sequential analysis in anesthesiology and intensive care, aiming to enhance the reliability and validity of clinical trial outcomes in these fields. His research is characterized by a rigorous approach to understanding and improving patient outcomes through evidence-based practices and innovative therapeutic interventions.

Award and Honors

Valery Likhvantsev has been recognized for his significant contributions to anesthesiology and intensive care medicine. His awards and honors reflect his dedication to advancing the field through innovative research and clinical excellence. He has received multiple accolades for his published works, highlighting the impact and importance of his research in improving patient outcomes and advancing medical knowledge. These honors underline Likhvantsev’s role as a leading figure in his area of expertise, acknowledging his commitment to excellence and his influence in shaping contemporary anesthesiology and intensive care practices.

Research Skills

Valery Likhvantsev possesses a robust set of research skills that underscore his expertise in anesthesiology and intensive care medicine. His proficiency in clinical trial design and implementation ensures rigorous and reliable study outcomes, while his adeptness in systematic reviews and meta-analyses enables comprehensive evaluations of existing research. He is skilled in statistical analysis, which allows for precise interpretation of complex data, and his ability to conduct trial sequential analysis adds a layer of depth to his research. Additionally, Likhvantsev is proficient in writing and publishing scholarly articles, contributing to high-impact journals in his field, thus disseminating crucial findings to the wider medical community.

Publications

  1. Sevoflurane Multiple Wash In/Wash Out at the End of Anesthesia to Reduce Agitation: A Multicenter Double-Blind Randomized Controlled Trial
    • Authors: Landoni, G., Likhvantsev, V.V., Berikashvili, L.B., Pivovarova, A.A., Shemetova, M.M.
    • Year: 2024
    • Citations: 0
    • Journal: Contemporary Clinical Trials Communications
  2. Trial Sequential Analysis in Anesthesiology and Intensive Care: A Systematic Review | Последовательный анализ исследований в анестезиологии и реаниматологии: систематический обзор
    • Authors: Yadgarov, M.Ya., Berikashvili, L.B., Polyakov, P.A., Yakovlev, A.A., Likhvantsev, V.V.
    • Year: 2024
    • Citations: 0
    • Journal: Patologiya Krovoobrashcheniya i Kardiokhirurgiya
  3. Intraoperative Electroencephalogram Patterns as Predictors of Postoperative Delirium in Older Patients: A Systematic Review and Meta-Analysis
    • Authors: Likhvantsev, V.V., Berikashvili, L.B., Smirnova, A.V., Shemetova, M.M., Kuzovlev, A.N.
    • Year: 2024
    • Citations: 0
    • Journal: Frontiers in Aging Neuroscience
  4. Effect of Regional Anesthesia on Oncological Outcomes (Meta-Analysis)
    • Authors: Kadantseva, K.K., Yadgarov, M.Ya., Subbotin, V.V., Kuzovlev, A.N., Likhvantsev, V.V.
    • Year: 2024
    • Citations: 0
    • Journal: Obshchaya Reanimatologiya
  5. Melatonin as Adjuvant Treatment in COVID-19 Patients: A Meta-Analysis of Randomized and Propensity Matched Studies
    • Authors: Tóth, K., Pilia, E., Landoni, G., Székely, A., Covello, R.D.
    • Year: 2024
    • Citations: 0
    • Journal: Signa Vitae
  6. Hypotension-Avoidance Versus Hypertension-Avoidance Strategies in Noncardiac Surgery
    • Authors: Marcucci, M., Painter, T.W., Conen, D., Yusuf, S., Devereaux, P.J.
    • Year: 2023
    • Citations: 1
    • Journal: Annals of Internal Medicine
  7. Effects of Early Postoperative Neurocognitive Disorders on Clinically Relevant Outcomes: A Meta-Analysis
    • Authors: Likhvantsev, V.V., Landoni, G., Berikashvili, L.B., Makarevich, D.M., Grechko, A.V.
    • Year: 2023
    • Citations: 2
    • Journal: Korean Journal of Anesthesiology
  8. High Dose Esomeprazole as an Anti-Inflammatory Agent in Sepsis: Protocol for a Randomized Controlled Trial
    • Authors: Monti, G., Konkayev, A., Carta, S., Usai, B., De Sio, A.
    • Year: 2023
    • Citations: 0
    • Journal: Contemporary Clinical Trials
  9. Anakinra for Patients with COVID-19: An Updated Systematic Review and Meta-Analysis
    • Authors: Cavalli, G., Navalesi, P., Landoni, G., Monti, G., Pasin, L.
    • Year: 2023
    • Citations: 1
    • Journal: Signa Vitae
  10. Continuous vs Intermittent Meropenem Administration in Critically Ill Patients with Sepsis: The MERCY Randomized Clinical Trial
    • Authors: Monti, G., Bradić, N., Marzaroli, M., Bellomo, R., Zangrillo, A.
    • Year: 2023
    • Citations: 22
    • Journal: JAMA